FAIRMOUNT FUNDS MANAGEMENT LLC enters SPYRE THERAPEUTICS, INC. with 9.46M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.18M | Indirect |
| Common Stock | 276.08K | Indirect |
| Total | 9.46M | 9.46M indirect |
Series A Preferred Stock
IndirectUnderlying shares
12.68M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Preferred Stock
IndirectUnderlying shares
424.36M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
IndirectUnderlying shares
1.95M
Shares owned
N/A
Exercise price
0.30
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
IndirectUnderlying shares
1.95M
Shares owned
N/A
Exercise price
0.30
Expiration
—
Exercise window
—
Series A Preferred Stock
IndirectUnderlying shares
85.89M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Underlying
526.82M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock | — | — | 12.68M | N/A | |
| Series A Preferred Stock Indirect | Common Stock | — | — | 424.36M | N/A | |
| Stock Option (Right to Buy) Indirect | Common Stock | 0.30 | — | — | 1.95M | N/A |
| Stock Option (Right to Buy) Indirect | Common Stock | 0.30 | — | — | 1.95M | N/A |
| Series A Preferred Stock Indirect | Common Stock | — | — | 85.89M | N/A | |
| Total | 526.82M | 0.00 | ||||